Vitrolife AB (publ) (STO:VITR)

Market Cap	22.90B
Revenue (ttm)	3.61B
Net Income (ttm)	513.00M
Shares Out	135.39M
EPS (ttm)	3.78
PE Ratio	44.74
Forward PE	33.89
Dividend	1.10 (0.65%)
Ex-Dividend Date	Apr 30, 2025

Volume	63,307
Average Volume	295,243
Open	166.80
Previous Close	169.10
Day's Range	163.40 - 167.60
52-Week Range	156.00 - 268.00
Beta	1.76
RSI	34.28
Earnings Date	Mar 27, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,120
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR